Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide
Aim: Dimethylsulfoxide (DMSO) is the most frequently used agent for hematopoietic cell (HC) graft cryopreservation. This study aimed to monitor blood pressure and heart rate (HR) during HC graft infusion and assess the impact of cryopreservation with DMSO. Methods: 153 HC graft infusions in 153 co...
Gespeichert in:
Datum: | 2009 |
---|---|
Hauptverfasser: | Horacek, J.M., Jebavy, L., Jakl, M., Zak, P., Mericka, P., Maly, J. |
Format: | Artikel |
Sprache: | English |
Veröffentlicht: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2009
|
Schriftenreihe: | Experimental Oncology |
Schlagworte: | |
Online Zugang: | http://dspace.nbuv.gov.ua/handle/123456789/135722 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
Zitieren: | Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide / J.M. Horacek, L. Jebavy, M. Jakl, P. Zak, P. Mericka, J. Maly // Experimental Oncology. — 2009. — Т. 31, № 2. — С. 121–122. — Бібліогр.: 15 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineÄhnliche Einträge
-
Assessment of anthracycline-induced cardiotoxicity with electrocardiography
von: Horacek, J.M., et al.
Veröffentlicht: (2009) -
Evaluation of serum levels of multiple cytokines and adhesion molecules in patients with newly diagnosed acute lymphoblastic leukemia using biochip array technology
von: Horacek, J.M., et al.
Veröffentlicht: (2013) -
Biochip array technology and evaluation of serum levels of multiple cytokines and adhesion molecules in patients with newly diagnosed acute myeloid leukemia
von: Horacek, J.M., et al.
Veröffentlicht: (2014) -
Survival rates of familial and sporadic prostate cancer patients
von: Plonis, J., et al.
Veröffentlicht: (2015) -
Treatment of metastatic head and neck cancer with mesenchymal stem cells combined with prodrug gene therapy
von: Lakota, J., et al.
Veröffentlicht: (2015)